Dr. C. Pantos received his degree in Medicine and his PhD from Medical School of Athens. He is trained in Clinical and Invasive Cardiology at the University College & Middlesex Hospital, London, UK. He is currently Professor and Head of  the Department of Pharmacology, Medical School, University of Athens. He is editor of the book entitled “Myocardial ischemia : from mechanisms to therapeutic potentials” by Cokkinos/ Pantos / Heusch / Taegtmeyer (Eds), Springer, 2006. For the last 20 years, his research is focused on the role of thyroid hormone in tissue regeneration (myocardium, neural tissue, pancreas, sepsis) and especially on endogenous mechanisms of repair/regeneration after myocardial injury. This research has resulted in a Phase II clinical trial  (Thy-Repair) testing the effects of T3 in patients with acute myocardial infarction. (EudraCT:2016-000631-40). He has significant experience in design of clinical trials and repositioning of old drugs to other indications. He was one of the clinical experts in the EC funded project “Efficient Patient Recruitment for Innovative Clinical Trials of Existing Drugs to other Indications” (PONTE). 

Dr. Pantos has published more than 120 scientific papers in international, peer-review journals His work has received more than 3800 citations (Google Scholar, h-index 39). He has also served as a guest editor in 4 special issues. He has several research collaborations with the pharmaceutical industry (Gilead, Menarini, Sanofi-Aventis, Servier, Uni-Pharma Laboratories S.A.)

Dr. Lourbopoulos is a Neurologist (Board Certified in 2013) with translational training background. He received his medical training and PhD ("Stem cell transplantation in experimental stroke") in the Aristotle University of Thessaloniki (2009) and conducted post-doctoral basic research and studies in the Institute for Stroke and Dementia Research LMU-Munich (since 2013) and Charite Medical School Berlin (2014-2016). Since 2017 he works in a renowned Center for Neurological Diseases in Munich (Schoen Klinik Bad Aibling), focused in vascular stroke and Neurointensive care. His work so far combines translational basic research and clinical activity with emphasis on Stroke and Neuroimmunology. His current research interest remains stroke with focus on neuroimmunology, its remote effects and post-cerebral neuroplasticity. He has been supported by various scholarships and research programs (IKY Fellowship, European Neurological Society Fellowship, Marie-Curie Fellowship, Sanofi Fellowship, Unipharma Grant for Stroke and Sepsis research). He is the inventor of 1 international patent for new drugs.

In 2018, he established the Group of Translational Neurology Research (GTNR) in the Department of Pharmacology in Athens Medical School, under the support of Prof. K. Pantos (Director of the Dept.) and the Assoc. Prof. I. Mourouzis. Within this time, he de novo established the complete study suite of the experimental stroke in mice (stroke model, behavioral analysis, microscopy and in vitro studies) and Microscopy/Neuropathology in the Department of Pharmacology.

Dr.  Mourouzis received his degree in Medicine from University of Athens (2001) and PhD in “Thyroid hormone and cardioprotection” (2006, University of Athens). He is a trained cardiologist and is currently Associate Professor  in the Department of Pharmacology, Medical School, University of Athens. He is the scientific coordinator of the GNPAC team. He has considerable experience in experimental models of isolated rat hearts, in vivo model of ischemia-reperfusion, echocardiograqphy in mice and rats, biochemical and molecular techniques. His research is focused on the role of thyroid hormone in tissue repair  (myocardium, neural tissue, pancreas, sepsis) and especially on endogenous mechanisms of repair/regeneration after myocardial injury. This research has resulted in a Phase II clinical trial  (Thy-Repair) testing the effects of T3 in patients with acute myocardial infarction. (EudraCT:2016-000631-40). He is also involved in several experimental investigations about the role of old and new pharmacological interventions in tissue injury and repair  (ranolazine, amiodarone, dronedarone, trimetazidine, dobutamine, clenbuterol, phenylephrine, sildenafil, morphine). He is inventor of 1 international and 3 Greek patents for new drugs.

He was one of the clinical experts in the EC funded project “Efficient Patient Recruitment for Innovative Clinical Trials of Existing Drugs to other Indications” (PONTE) and has significant experience in translational research and statistics. He is the scientific coordinator for NKUA in the European program “Regenerating the diabetic heart and kidney by using stress-specific thyroid hormone nanocarriers” (EURONANOMED2019-049 / REASON, 2020-2023)

Dr. Mourouzis has published more than 100 scientific papers in international, peer-review journals. His work has received more than 3300 citations according to Google Scholar (h-index 37). He has published 3 chapters in international scientific books. He is one of the two representatives of National and Kapodistrian University of Athens in the HEALTH HUB Council of the CIVIS program, a European Civic University formed by the alliance of nine leading research higher education institutions across Europe.

Nefeli was born in Athens in 1996. She received her Medical Diploma from Athens Medical School at the National and Kapodistrian University of Athens in 2020. Her scientific interest is Neuroscience and in particular the fields of neurodegenerative diseases and stroke. In September 2018, she joined the GTNR Lab in order to expand her field of knowledge and to actively participate in basic brain research. She is a PhD candidate in the Lab since 2021 with focus on the pathophysiology of experimental ischemic stroke. 

Angelos was born in Athens in 1996. He received his Medical Diploma from Athens Medical School at the National and Kapodistrian University of Athens in 2020. The constant challenges in Neuroscience, the molecular basis of stroke and the possibilities for highly innovative interdisciplinary treatment approaches is what thrills him scientifically. In March 2019 he joined GTNR Lab in order to deepen into the basic research of vascular brain diseases. Since 2021 he is a PhD candidate in the Lab with focus on novel drugs for experimental ischemic stroke.

Makis was born in Athens. He received his Diploma for Electrical and Computer Engineering from the University of Patras in 2020. Scientifically he is thrilled by robotics, bioengineering, neural networks, machine learning but mostly by the fact that science can solve problems and broadens our horizons. On March 2019 he joined the GTNR Lab to have a better understanding on brain functions and complexity. Within his work in the Lab he developed de novo a novel machine-learning based algorithm for autonomous stroke-lesions detection. He is now an industrial PhD Student in the University of Lulea, in Sweden and remains an external collaborator of the Lab.

Nikolas Karvelas was born in Athens. He is a medical doctor and aspiring neurologist. He graduated in 2021 from the School of Medicine of the National and Kapodistrian University of Athens. His scientific interests include stroke, dementias and neurological rehabilitation, both from a translational and clinical perspective. From 2021 he has been a member of the study team for chronic stroke in mice, in the GTNR Lab, in order to better understand its pathophysiology and possible therapeutic targets. Additionally, he has been a research associate of the Cognitive Disorders and Dementia group of the Eginition Hospital.

Michalis was born in Athens. He is an undergraduate student at the Medical School of Athens, at the National and Kapodistrian University of Athens.

Asterios was born in Athens. He is a senior undergraduate student at the Department of Biology at the National and Kapodistrian University of Athens. His scientific interests focus on Cellular and Molecular Biology, Immunology and Neurosciences. He is scientifically fascinated by the investigation of cellular interactions, signaling pathways, molecular mechanisms, as well as the research for innovative treatments. In February 2022, he joined the GTNR Lab in the context of his Diploma Thesis entitled: "Molecular pathway-changes in peripheral immune cells after ischemic damage".

Nikos was born in Larissa. He graduated in 2022 from the School of Medicine of the National and Kapodistrian University of Athens.

Ioanna was born in Ioannina in 2000. She is a final year student at the Department of Electrical and Computer Engineering at the University of Patras. Her passion lies in the field of Biomedical Engineering, with a particular focus on utilizing machine learning and deep learning methodologies to tackle medical challenges.